Agoracom Blog

Else Nutrition Holdings Inc. $BABY.ca to Webcast Live at VirtualInvestorConfences October 8th $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 7:18 AM on Monday, October 5th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png

Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com

VANCOUVER, BC / October 5, 2020 / ELSE NUTRITION HOLDINGS INC. (TSXV:BABY)(OTCQX:BABYF)(FSE:0YL) (“Else” or the “Company“), a developer of plant-based alternatives to dairy-based baby nutrition today announced that [Hamutal Yitzhak], [CEO], will present at VirtualInvestorConferences.com on October 8th.

DATE: Thursday, October 8th

TIME: 4:00 PM ET

LINK: https://bit.ly/3bLR2RF

If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.

It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates.

Learn more about the event at www.virtualinvestorconferences.com.

Recent Company Highlights

  1. Recent CAD $ 25M financing and use of proceeds
  2. Recent Amazon and website launch.
  3. Current US distribution agreements and updated plans for retail rollout.
  4. H&H Global Group, company’s largest investor increased their stake in the last round of financing, and the new territories distribution and expansion plans.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. The holding company, Else Nutrition Holdings Inc, is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.

About Virtual Investor Conferences®
Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly-traded companies to meet and present directly with investors.

A real-time solution for investor engagement, Virtual Investor Conferences is part of OTC Market Group’s suite of investor relations services specifically designed for more efficient Investor Access. Replicating the look and feel of on-site investor conferences, Virtual Investor Conferences combine leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

For more information, contact:

Ms. Hamutal Yitzhak, CEO, Co-Founder & Director
ELSE Nutrition Holdings Inc.
E: [email protected]
P: +972(0)3-6445095

Mr. Sokhie Puar, Director of Else Nutrition
Email: [email protected]
Telephone: 604-603-7787

Virtual Investor Conferences

John M. Viglotti
SVP Corporate Services, Investor Access
OTC Markets Group
(212) 220-2221
[email protected]

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will”, “expect” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that listing on the FSE will create additional liquidity and attract additional investors in the European market. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Loop Insights $MTRX.ca Files Provisional Patents And Trademark Registries For Venue Tracing And #Contactless Solution Applications In Wake Of Growing Demand $RACMF $QUIS.ca $MCLD.ca $NXO.ca

Posted by AGORACOM-JC at 7:15 AM on Monday, October 5th, 2020
https://miro.medium.com/max/3150/1*f9msDHyceA_TbRM30jQhsw.png
  • Announces the filing of provisional patent applications and various Trademark Registries for its contactless data applications
  • The filings come in the wake of both actual integrations with globally renowned customers and a substantial increase in demand from various verticals, including college sports, professional sports, hotels, TV & movie productions, and hospitality & entertainment, amongst others

VANCOUVER, British Columbia, Oct. 05, 2020  — Loop Insights Inc. (MTRX:TSXV OTCQB:RACMF) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive automated marketing, contact tracing, and contactless solutions to the brick and mortar space, announces the filing of provisional patent applications and various Trademark Registries for its contactless data applications. The filings come in the wake of both actual integrations with globally renowned customers and a substantial increase in demand from various verticals, including college sports, professional sports, hotels, TV & movie productions, and hospitality & entertainment, amongst others.

Loop’s venue tracing platform is unique in that it requires no app download and only a tap of the user’s device to check-in for protection and alerts. Loop’s SmarTap devices are installed at multiple points to log every individual that enters a venue by check-in using the Loop contact tracing wallet pass. Loop’s solution allows venue staff to quickly identify individuals that were in proximity to any infected person and isolate potentially infected individuals as quickly as possible for follow-up testing.

Moreover, Loop’s contactless ticketing and e-commerce solution adds a further layer of protection by removing this very manual process, while also delivering artificial intelligence driven marketing solutions to provide real-time personalized promotions and targeted engagement that reinvent the live customer experience.

As a result, Loop’s venue tracing and contactless solutions platform provides live event operators with the ability to safely reopen by transforming their venues into 100% digital and cashless environments with contactless entry, contactless payments, and never before seen customer engagement that not only resumes revenue-generating operations but expand them.

Rob Anson, CEO of Loop Insights, stated, “Interest in Loop’s integrated contactless platform for tracing, ticketing, targeting, and engagement by live event operators has been significant over the past couple of months as they desperately search for best of breed solutions that will allow them to safely restart operations and generate much needed revenue. Our turnkey contactless solutions platform has turned a lot of heads around the world, and we intend to capitalize on this opportunity, given how well-positioned we are to become a global leader.”

This Press Release Is Available On The Loop Insights Verified Forum On AGORACOM For Shareholder Discussion and Q&A https://agoracom.com/ir/LoopInsights/forums/discussion

About Loop Insights:
Loop Insights Inc. is a Vancouver-based Internet of Things (“IoT”) technology company that delivers transformative artificial intelligence (“AI”) automated marketing, contact tracing, and contactless solutions to the brick and mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia.

For more information, please contact:
Loop Insights Inc.LOOP Website: www.loopinsights.ai
Rob Anson, CEOFacebook: @ LoopInsights
T: +1 877-754-5336 Ext. 4Twitter: @ LoopInsights
E: [email protected]LinkedIn: @ LoopInsights
  

Forward-Looking Statements/Information:

This news release contains certain statements which constitute forward-looking statements or information. Such forward-looking statements are subject to numerous risks and uncertainties, some of which are beyond Loop s control, including the impact of general economic conditions, industry conditions, and competition from other industry participants, stock market volatility and the ability to access sufficient capital from internal and external sources. Although Loop believes that the expectations in its forward-looking statements are reasonable, they are based on factors and assumptions concerning future events which may prove to be inaccurate. Those factors and assumptions are based upon currently available information. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors that could influence actual results or events and cause actual results or events to differ materially from those stated, anticipated or implied in the forward-looking statements. As such, readers are cautioned not to place undue reliance on the forward-looking statements, as no assurance can be provided as to future results, levels of activity or achievements. The forward-looking statements contained in this news release are made as of the date of this news release and, except as required by applicable law, Loop does not undertake any obligation to publicly update or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise. The forward-looking statements contained in this document are expressly qualified by this cautionary statement. Trading in the securities of Loop should be considered highly speculative. There can be no assurance that Loop will be able to achieve all or any of its proposed objectives.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

CLIENT FEATURE – The 3 Reasons Why Arctic Star Is A World Class, Small Cap Diamond Explorer $ADD.ca $RIO $DIAM.ca $NAR.ca

Posted by AGORACOM at 2:53 PM on Friday, October 2nd, 2020

The 3 Reasons Why Arctic Star Is A World Class, Small Cap Diamond Explorer

Arctic Star Exploration (ADD:TSXV / ASDZF:OTCQB / 82A1.F:FRA) is in the diamond finding business.

The Company owns 100% of its flagship Timantti Diamond Project in Finland, where Arctic Star has discovered three diamondiferous kimberlites that may represent the first finds in a large kimberlite field. If you don’t know what a kimberlite is, keep drilling down and see below because this is truly exciting.

The project is located on the same geological belt as the Grib Diamond Mine in Russia, just 450 kms away. The Grib mine is one of the largest diamond mines in the world and was discovered by a team led by Arctic Star Director Roy Spencer.  Keep drilling down to see more about him.

For those investors who have a little more experience and find themselves asking Why Finland? You should know that Finland was ranked as the World’s #2 mining jurisdiction in the world by the Fraser Institute 2020. In addition to its flagship project in Finland, the Company also controls diamond exploration properties in Nunavut (Stein) and the Northwest Territories of Canada (Diagras and Redemption).

But the real secret of Arctic Star is that it has tremendous potential to revolutionize the way in which Diamonds are discovered – and become a pioneer in the exploration industry – by finding diamonds in a place where no previous explorer has thought to do so. More than just a wild theory, Arctic Star has the team to back it up.

Here are the 3 things you need to know

1. World Class Diamond Finders

Arctic Star exploration has a highly experienced diamond exploration team previously responsible for numerous world class diamond mine discoveries.  The team is led by Buddy Doyle who originally discovered Diavik Mine, Canada’s largest diamond mine in terms of carat production. Diavik’s exceptional grades make it one of the most valuable diamond mines in the world.  Diavik is located in the Northwest Territories of Canada, where Arctic Star has 2 of their diamond properties.

Few geologists have seen 2 projects from discovery through to decision to mine. Mr. Doyle is recognized by his peers in the exploration industry as an authority on diamond exploration and kimberlite geology, and has authored/co-authored numerous papers on these subjects. He was awarded the 2007 Hugo Dummitt Award for excellence in Diamond exploration.

Roy Spencer – If that wasn’t enough, the geologist who discovered the multi-billion-dollar Grib Diamond Mine in Russia (see above). which is just 450 KMs away from Arctic Star’s project in Finland, has now joined Arctic’s Board of Directors!  Clearly, the Arctic Star team has the credibility necessary to put forth a new thesis on how to find diamonds. 

 2. Brand New Exploration Model To Find Diamonds 

In order to find diamonds, you need to first find Kimberlites. What are Kimberlites? Essentially, they are the rocks which contain diamonds. These kimberlite rocks are found underground in vertical structures known as kimberlite pipes. To illustrate in simple terms, see this basic image of a kimberlite pipe with kimberlite rocks inside of it.  

Kimberlite pipes are the biggest source of diamonds today. When exploration companies go looking for kimberlites, the industry standard for finding them is to look for magnetic signatures. This is done by taking a magnetic survey from the air and/or ground. with a device called a magnetometer.  Now, most of you won’t understand what you are looking at – but here is an example of one of the company’s magnetic surveys on its Canadian Diagras property.

The most important thing to understand is that the industry looks for magnetic signatures ….. but Buddy Doyle and the accomplished Arctic Star team have developed a NON MAGNETIC THESIS.  They believe they will find economic diamonds by locating Kimberlite that do not have a magnetic signature where previous explores sought not to look. Arctic in a sense is exploring for diamonds the opposite way the industry traditionally does. Arctic acquired property big mining company’s dropped, because they looked at them one way. Arctic is looking differently and success is occurring quickly for this small, yet accomplished exploration outfit. There are already multiple drill ready targets in 2 countries using this new way of looking for diamonds.

Arctic offers multiple opportunities in 2 countries to turn the Diamond Industry on notice with a discovery.

3. Arctic Star Has Two Diamond Projects Ready To Verify Its Non-Magnetic Theory

Arctic has 2 diamond projects on which to verify its theory: Diagras in Northwest Territories of Canada and Timantti in Finland, where early exploration searching for Non-Magnetic signatures has already yielded multiple new diamond target

A.  Diagras is next to Diavik (Canada’s largest diamond mine) and is drill ready to prove Buddy’s theory. Arctic has plans to drill in 2020

B. Timantti in Finland has 3 separate target areas and 6 targets altogether identified through non-magnetic signatures as a means to find diamonds and further excel Buddy’s theory, it is the company’s goal to drill test in 2020

If Buddy Doyle and the Arctic Star team are correct it will create a new discovery process for understanding how diamonds are brought to surface in areas previous explorers cared not to look. Arctic Star has the potential to create multiple discoveries and copycat companies trying to duplicate their success.

However, there is only one Buddy Doyle and Roy Spencer, which is why Arctic Star is the one Diamond Exploration Company every investor should be aware of.

Click Here To Discover Why Arctic Star Is The Next Diamond Discovery

MedX Health Corp. $MDX.ca Bolsters Global Footprint and Adds Renowned Skin Care Expert to Senior Leadership Team $DMTK $ICAD $PLSE $SRTS

Posted by AGORACOM-JC at 2:36 PM on Friday, October 2nd, 2020
Home - MedX Health
  • Announced the appointment of veteran healthcare industry executive Naman Demaghlatrous as Managing Director, Europe, Middle East & Africa, effective immediately
  • Additionally, Chantal Ward, RN has taken a permanent position with the Company as Director, Dermatological Services.

MedX Health Corp. (“MedX”) (TSX-V: MDX) is pleased to announce the appointment of veteran healthcare industry executive Naman Demaghlatrous as Managing Director, Europe, Middle East & Africa (“EMEA”), effective immediately. Additionally, Chantal Ward, RN has taken a permanent position with the Company as Director, Dermatological Services.

“Naman’s extensive background in healthcare and medical devices, along with his deep relationships will allow us to accelerate business development opportunities in the region,” said Mike Druhan, President of Dermatological Products & Services. “Chantal is an internationally recognized and respected leader in the dermatology and aesthetics spaces, bringing credibility to our offerings and putting an impressive opinion leader network at our disposal.”

Mr. Demaghlatrous has more than 20 years of experience in the healthcare industry, including roles with medical device and pharmaceutical companies leading business strategy, international product licensing, business development and operations. He has proven expertise in leading organizations through start-up to rapid growth, expansion and value creation with companies such as Medtronic, Pediapharm, Johnson & Johnson and Atfal Pharma. Mr. Demaghlatrous will play an integral part in MedX’s revenue growth prospects by securing European, Middle Eastern and African partnerships for MedX’s skin assessment telemedicine technology. Initially supporting the roll out and expansions in the Netherlands, Spain and Turkey, he will also be responsible for securing joint ventures and partnerships across the EMEA Region.

“Helping patients access an e-consult on suspicious lesions or moles quickly and easily means better treatment and better outcomes,” noted Mr. Demaghlatrous. “There is already significant interest and traction across the region and I am expecting substantial growth over the next six to nine months.”

Chantal Ward RN, a Diploma Nurse Graduate from an operating room background, has 20+ years’ experience as a clinical trainer of advanced medical aesthetic equipment and technology. Her expertise is acknowledged across Canada and around the world, where she has provided guidance and training to hundreds of medical aesthetic professionals. Ms. Ward is Co-Founder of Clarity MedSpa & Laser Centre, Toronto and has significant experience with MedX’s SIAscopy on DermSecure™.

“I have been using this device in my clinic for several years and have caught multiple melanomas,” said Ms. Ward. “The device is easy to use and the ability to have a dermatologist provide a remote e-consult, within 72 hours, is critical. Early detection is the key to a successful patient outcome.”

“MedX is in full commercialization mode and Naman and Chantal are welcomed additions to our team. Recently, Damon Goodwin and Nick Hoffman have been announced to our senior management team and we are already feeling their impact. It is a satisfying to know that MedX can attract such seasoned professionals and I strongly believe that is because of the strength of our technology offering and the culture we have built,” further commented Mr. Druhan.

Currently, between two and three million non-melanoma skin cancers and 300,000 melanoma skin cancers occur globally each year. One in every three cancers diagnosed is a skin cancer and, according to Skin Cancer Foundation statistics, one in every five people will develop skin cancer in their lifetime. The global demand for SIAscopy on DermSecure™ will continue to increase with the growth of telemedicine and as early detection is recognized as the way to optimize survival and reduce healthcare costs.

About MedX

MedX, headquartered in Mississauga, Ontario, is a leading medical device and software company focused on skin health with its SIAscopy on DermSecure™ telemedicine platform, utilizing its SIAscopy™ technology. SIAscopy is also imbedded in its products SIAMETRICS™, SIMSYS™, and MoleMate™, which MedX manufactures in its ISO 13485 certified facility. SIAMETRICS™, SIMSYS™, and MoleMate™ include hand-held devices that use patented technology utilizing light and its remittance to view up to 2 mm beneath suspicious moles and lesions in a pain free, non-invasive manner, with its software then creating real-time images for physicians and dermatologists to evaluate all types of moles or lesions within seconds. These products are Health Canada, FDA, TGA and CE cleared for use in Canada, the US, Australia, New Zealand, the European Union and Turkey. MedX also designs, manufactures and distributes quality photobiomodulation therapeutic and dental lasers to provide drug-free and non-invasive treatment of tissue damage and pain. www.medxhealth.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This Media Release may contain forward-looking statements, which reflect the Company’s current expectations regarding future events. The forward-looking statements involve risks and uncertainties.

Mike Druhan, President, Dermatological Services
MedX Health Corp
Tel: 905-599-7852

KWESST $KWE.ca Appoints Chief Financial Officer $WRTC $BYRN.ca $PAT.ca $POWW

Posted by AGORACOM-JC at 4:46 PM on Thursday, October 1st, 2020
  • Announced the appointment of Steven Archambault, CPA, CA as the Company’s new Chief Financial Officer
  • Mr. Archambault brings a wealth of international finance experience to KWESST. With 15 years of public company experience, he has deep functional expertise and technical knowledge in all aspects of corporate finance, financial planning, and accounting, in addition to merger and acquisitions.
  • Mr. Archambault will commence immediately, replacing Paul Kania.

Ottawa, Ontario–(October 1, 2020) – KWESST Micro Systems Inc. (TSXV: KWE) (“KWESST” or “the Company”) today announced the appointment of Steven Archambault, CPA, CA as the Company’s new Chief Financial Officer.

Mr. Archambault brings a wealth of international finance experience to KWESST. With 15 years of public company experience, he has deep functional expertise and technical knowledge in all aspects of corporate finance, financial planning, and accounting, in addition to merger and acquisitions. Mr. Archambault will commence immediately, replacing Paul Kania.

Mr. Kania has been on contract as CFO since November 2019 to position the Company for its going public transaction and will remain available to KWESST as an advisor to facilitate the transition. David Luxton, Executive Chairman, thanked Mr. Kania on behalf of the board for his assistance in getting the Company to this milestone.

“We’re delighted to welcome Steven Archambault on board,” added Mr. Luxton. “He has the rare combination of experience and ability to contribute to the Company’s strategic agenda as well as ensure operational excellence as the Company grows from here.”

Steven Archambault commented, “I’m excited to be joining the KWESST leadership team at a time when the Company continues to gain traction with its disruptive technologies in the defence and security community, and the potential for outsized growth on a global scale with superior returns to shareholders.”

Mr. Archambault’s appointment will initially be on a part-time employment basis for the next six months with KWESST having the option to convert the employment to a full-time indefinite period.

In connection with his appointment, Mr. Archambault has been granted 250,000 options exercisable at a price of $0.75 until September 29, 2025.

Steven Archambault Bio

Mr. Archambault began his career as a CPA, CA with Ernst & Young LLP, followed by senior finance positions at AXIS Capital, a global insurer and reinsurer, and more recently had CFO roles with small cap public Canadian companies listed on the TSX-V and CSE in media broadcasting technology and health & wellness industries.

About KWESST

KWESST develops and commercializes high-value ultra-miniaturized technology applications that make a critical difference to the safety and operational effectiveness of personnel in the defence and security industries. The company’s current portfolio of unique proprietary offerings include: its signature TASCSTM (Tactical and Situational Control System) for real-time awareness and targeting information from any source (including drones) streamed directly to users’ smart devices and weapons; the autonomous Grey GhostTM soldier-portable micro drone missile system that defends against small hostile drones including swarms using high-speed kinetic impact; a Ground Laser Defence system to counter the emerging threat of weaponized lasers against personnel; and, the PhantomTM electronic battlefield decoy system to mask the electromagnetic signature of friendly forces with decoy signatures at false locations to deceive and confuse adversaries. All systems can operate stand-alone or integrate seamlessly with OEM products and battlefield management systems including Frontline, Edge, Killswitch and ATAK (Android Tactical Assault Kit) among others. KWESST also has developmental “smart ordnance” projects including its “Shot Counter” system, which records the number and type of rounds fired, for optimized firearms maintenance and performance. The Company is headquartered in Ottawa, Canada, with representative offices in Washington, DC, London, UK and Abu Dhabi, UAE. KWESST trades on the TSX Venture Exchange under the symbol KWE.

Contact:
Jason Frame, Investor Relations.
Email: [email protected]

For more information please visit www.kwesst.com.

Cautionary Note Regarding Forward-Looking Statements

This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to the timing for the commencement of trading and the plans and operations of KWESST after giving effect to the Qualifying Transaction. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. KWESST disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

Datametrex $DM.ca CEO Provides an Update to Shareholders

Posted by AGORACOM-JC at 12:09 PM on Thursday, October 1st, 2020
Webinar logo

Toronto, Ontario–(October 1, 2020) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex”) is pleased to provide an update to the market and shareholders from its Chief Executive Officer, Marshall Gunter:

“I believe that it is important for our shareholders to understand our achievements and growth plan.

Since our recent Information Circular for Annual General Meeting (AGM) was registered, there has been much confusion on the topic of a potential consolidation of the shares. The ability to consolidate a company’s share float has been used by many public companies in the past to elevate itself to a larger exchange. Datametrex reserves the right to consolidate our shares, if warranted, for an uplisting to another major exchange. At this time, we do not intend to consolidate the shares nor plan to. We are focused on growing all of the businesses within Datametrex.

We are focused on the expansion of our Artificial Intelligence (AI) business in various verticles. The pace with clients continues to be rapid. This is illustrated with the addition of increased business from global clientele such as LOTTE and 7/11 in South Korea as well as government agencies in both Canada and the United States.

The global markets are demanding seamless solutions to improve their bottom line. We at Datametrex have proven that we enable them to do just that. To have these clients is a real testament to our team of professionals who are working around the clock to secure our future success with our AI suite of services.

We continue to report success within our line of coronavirus solutions. The interest continues to grow, as we have illustrated in our recent press releases. To date, we have been approached by numerous companies across many sectors. I am pleased with what we have achieved.

Our indication of profitability is in a range between 20% and 40%. We deliver secured reporting and testing solutions that are FDA, Health Canada, and CE approved. This gives our clients the capability to support and protect their employees and clients.

Datametrex can adapt and serve the ever-changing coronavirus landscape. It is a terrible situation for our country. We do not take this lightly. I am confident in all the services we are providing. Datametrex will update the market on developments in future communications when material.

We are in the final stages of filing our OTC QB listing in the US. I am glad to state that our filing has been submitted, and our timing is on track with the US regulators.

I thank all of our shareholders who have and continue to support us. We are committed to you. Thank you.”

About Datametrex

Datametrex AI Limited is a technology-focused with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

Certain statements including in this news release contain “forward-looking information” or constitute “forward-looking statements” within the meaning of applicable securities laws. Such forward-looking statements or information are provided for the purpose of providing information about management’s current expectations and plans relating to the future. Readers are cautioned that reliance on such information may not be appropriate for other purposes In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy, including the dollar amount of revenue anticipated under the Agreement.

Forward-looking statements or information are based on current expectations, estimates and projections that involve several risks and uncertainties, which could cause actual results to differ materially from those anticipated by the Company and described in the forward-looking statements or information. These risks and uncertainties may cause actual results to differ materially from the forward-looking statements or information.

Readers are cautioned that the foregoing list is not exhaustive of all possible risks and uncertainties. Readers are also cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the time such forward-looking information is made. Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Primo Nutraceuticals Inc. $PRMO.ca Signs Letter of Intent with Brujera Elixirs Inc. to Formulate 4 Innovative Adaptogenic Mushroom-Infused Beverage Products

Posted by AGORACOM-JC at 9:41 AM on Thursday, October 1st, 2020
  • Company has decided to continue down that path by announcing that it has entered into a non-binding letter of intent (the “LOI”) with Brujera Elixirs Inc. (“Brujera”) to formulate an exclusive line of 4 “Innovative adaptogenic mushroom-infused” beverage products for the natural health and wellness market.
  • Product development and steps for final formulation will commence immediately upon signing of the definitive agreement with Brujera; which is expected to occur on or before October 30, 2020

VANCOUVER, British Columbia, Oct. 01, 2020 — PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVD) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“Primo Nutra” or the “Company”) Further to the Company’s news release dated May 22, 2020 announcing that Primo Nutra received its Natural Product Number (“NPN) from Health Canada, the Company has decided to continue down that path by announcing that it has entered into a non-binding letter of intent (the “LOI”) with Brujera Elixirs Inc. (“Brujera”) to formulate an exclusive line of 4 “Innovative adaptogenic mushroom-infused” beverage products for the natural health and wellness market.

Product development and steps for final formulation will commence immediately upon signing of the definitive agreement with Brujera; which is expected to occur on or before October 30, 2020.

The specific types of functional mushrooms which will be used in formulating Primo Nutra’s exclusive beverages will be: Reishi , Cordyceps, Lion’s Mane and Chaga.

The Company was granted its first NPN ( 80099466) on May 22, 2020 for their lemon hand sanitizer. Primo Nutra will be focused on introducing 8 different natural health products to Canada’s health and wellness market.

About Brujera Elixirs Inc.

Launched by award winning B.C. master mixologist, sommelier and entrepreneur Kelly Ann Woods, Brujera is a house of brands which currently includes Boozewitch (sober-curious mixers) and State B Cannabis Beverage Co.Ms. Woods is an entrepreneur who has founded multiple companies in the CBD, cannabis, alcohol and non-alcohol beverage industry. In the last year, Kelly was named the 2019 RBC Canadian Woman Entrepreneur of the Year Award for Micro -Business Award ( https://www.youtube.com/watch?v=oLi9JSnhJ64 ). Woman of the Year from BC Business in addition to a CANIE Woman Entrepreneur award.

Nicknamed the “Boozewitch,” Quebec-born Kelly attended CEGEP in Montreal with a focus on theatre and worked as a flight attendant for Air Canada before moving to the West Coast. She spent years honing her drinks skills as a sommelier and doing hospitality work, all the while experimenting with beverage formulation. She is actively bringing a cannabis beverage to the US and Canadian markets under the name State B and opening an oceanfront wine bar in Squamish with a team of accomplished women in hospitality.

TERMS OF THE TRANSACTION

The LOI was signed on July 14, 2020. Pursuant to the LOI Primo Nutra and Brujera will seek to enter into a Definitive Consulting Agreement whereby Primo Nutra will create white label mushroom infused drinks for distribution in Canada and international markets while Brujera will create unique exclusive formulations for Primo Nutra’s mushroom-infused energy shot drinks.

Richard Cindric, CEO of Primo Comments:

“Ms. Woods experience in formulating functional CBD, cannabis, and alcoholic beverages is what we are looking for in a white-label partner. We are confident she is the right partner to introduce a mushroom based energy drink to compete with brands like Boost and Ensure. We are in a better position now than a year ago to peruse a line of energy drinks, as it was important to get a NPN number from Health Canada first.”

Kelly Ann Woods, CEO of BRUJERA Comments:

“We are pleased to be aligning ourselves with Primo for this line of adaptogenic mushroom drinks. At a time when immunity and cognitive function are at the forefront of people’s minds, this product is sure to be one in many people’s daily regime.”

The Global Energy Drink Market

According to Allied Market Research, the global energy drinks market size was valued at USD$53B in 2018 and is expected to reach USD$86B by 2026. https://www.alliedmarketresearch.com/energy-drink-market

About Primo Nutraceuticals Inc.

Primo Nutraceuticals Inc. (“Primo” or the “Company”) is dedicated to funding the rapid growth in production, processing, retail and branding of cannabis and non-cannabis natural health products in Canada and the United States. Primo has invested in several brands and is pursuing partnerships with retailers and distribution companies in Canada and the United States. Primo Nutra’s management is in the process of building a corporate road map to further vertically integrate the Company, specifically by way of the “Primo” & “Thrive,” brands and a selection of curated partner brands. Most recently Primo announced that it had received its NPN and it has been issued a Medical Device Establishment License (MDEL) from Health Canada.

On behalf of the Board of Directors

PRIMO NUTRACEUTICALS INC.

Andy Jagpal

Andy Jagpal
President and Director

For further information, please contact Zoltan, IR Representative at: 604-722-0305, or; [email protected] .

To learn more about what this news means to the shareholders visit:

www.primonutraceuticals.com
www.twitter.com/Prmoinc
www.thrivecbd.com
www.mariannacorp.com
www.dcppe.net
www.statebelevate.com

FORWARD LOOKING STATEMENTS: This news release contains certain forward-looking statements within the meaning of Canadian securities laws. Forward-looking statements are based on the expectations and opinions of the Company’s management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise. No regulatory authority has approved or disapproved the information contained in this news release.

PyroGenesis’ $PYR.ca CEO Files Early Warning Report; Reflects Increase in Ownership by 3.225 Million Shares $RTN $NOC $UTX $DDD.ca $SSYS $PRLB

Posted by AGORACOM-JC at 9:37 AM on Thursday, October 1st, 2020
  • As a result of the conversion of the Loan Mr. P. Peter Pascali, the Chief Executive Officer and President of the Company, (i) beneficially owns and controls 60,327,941 Common Shares, (ii) controls 7,251,000 Common Shares beneficially owned by 8339856 Canada Inc. (the “ Holdco ”), and (iii) controls 9,459,781 Common Shares beneficially owned by the Trust.
  • This represents, in aggregate, 77,038,722 Common Shares or slightly over 50.00% of the issued and outstanding Common Shares which are, in aggregate, 154,067,292 Common Shares

MONTREAL, Oct. 01, 2020 — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX-V: PYR) (OTCQB: PYRNF) (FRA: 8PY), a high-tech company, (the “Company”, the “Corporation” or “PyroGenesis”) that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch products, announces today that its CEO filed an early warning report. This early warning report reflects the conversion by Fiducie de Crédit Mellon Trust (the “ Trust ”) of a convertible loan of $903,000 (the “ Loan ”) into 3,225,000 common shares of the Company (“ Common Shares ”) at the request of the Company in accordance with the terms of a loan agreement between the Trust and the Company dated March 18, 2020 (the “ Loan Agreement ”). The Loan Agreement was previously disclosed by the Company in a press release issued on March 18, 2020.

As a result of the conversion of the Loan (the “ Transaction ”), Mr. P. Peter Pascali, the Chief Executive Officer and President of the Company, (i) beneficially owns and controls 60,327,941 Common Shares, (ii) controls 7,251,000 Common Shares beneficially owned by 8339856 Canada Inc. (the “ Holdco ”), and (iii) controls 9,459,781 Common Shares beneficially owned by the Trust. This represents, in aggregate, 77,038,722 Common Shares (the “ Total Ownership ”) or slightly over 50.00% of the issued and outstanding Common Shares which are, in aggregate, 154,067,292 Common Shares. The Holdco is a Canadian holding company of which Mr. P. Peter Pascali is a director, executive officer and the sole shareholder, and the Trust is a Quebec family trust of which Mr. Pascali is a trustee, executive officer and beneficiary. The Trust and the Holdco may be considered to be joint actors with Mr. Pascali.

On a fully diluted basis, assuming all options fully vest, Mr. Pascali together with Holdco and the Trust would beneficially own and control 52.19% of the issued and outstanding Common Shares of the Corporation.

About PyroGenesis Canada Inc.

PyroGenesis Canada Inc., a high-tech company, is the world leader in the design, development, manufacture and commercialization of advanced plasma processes and products. We provide engineering and manufacturing expertise, as well as turnkey process equipment packages to the defense, metallurgical, mining, advanced materials (including 3D printing), oil & gas, and environmental industries. With a team of experienced engineers, scientists and technicians working out of our Montreal office and our 3,800 m2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. Our core competencies allow PyroGenesis to lead the way in providing innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. Our operations are ISO 9001:2015 and AS9100D certified, and have been since 1997. PyroGenesis is a publicly-traded Canadian Corporation on the TSX Venture Exchange (Ticker Symbol: PYR) and on the OTCQB Marketplace. For more information, please visit www.pyrogenesis.com .

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward- looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Corporation’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Corporation with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Corporation’s ongoing filings with the securities regulatory authorities, which filings can be found at www.sedar.com, or at www.otcmarkets.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Corporation undertakes no obligation to publicly update or revise any forward- looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws. Neither the TSX Venture Exchange, its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) nor the OTCQB accepts responsibility for the adequacy or accuracy of this press release.

SOURCE PyroGenesis Canada Inc.
For further information please contact:
Rodayna Kafal, Vice President Investors Relations and Strategic Business Development,
Phone: (514) 937-0002, E-mail: [email protected]
RELATED LINK: http://www.pyrogenesis.com/

VIDEO – Soldier Launched Micro Drones, Electronic Soldier Decoys and a $93,000,000 Pipeline – Meet Brand New Listing KWESST Micro Systems $KWE.ca $WRTC $BYRN.ca $PAT.ca $POWW

Posted by AGORACOM-JC at 9:17 AM on Thursday, October 1st, 2020

If you haven’t heard of KWESST Micro Systems (KWE:TSXV) you’re not alone because the Company just listed for trading a couple of weeks ago – and it is probably the coolest new listing of 2020 if you love high-tech, covert defense systems that we only get to see in Tom Cruise movies.

KWESST is a leader in “soldier systems” which are technologies that increase the capabilities of soldiers,  Let’s be clear right off the start, KWESST doesn’t sell weaponry.  Rather, it sells technologies that make a big difference to the safety and effectiveness of soldiers.  

For example, out in a field of combat, soldiers emit Electro Magnetic (EM) signatures that make them detectable by enemy combatants.  KWESST has a battlefield decoy system that creates multiple false phantom signatures to spoof adversaries.  This picture is worth 1,000 words.  

 We could go on about many other such technologies created by KWESST but this is AGORACOM after all and we want to get down to the business of KWESST, the highlights of which are as follows:

  • A developer of next-generation systems for forces around the world, including those of NATO and its allies
  • A leadership team whose experience spans decades and hundreds of millions of dollars in military and homeland security contracts
  • A sales and distribution network of agents that spans the globe
  • Partnerships with globally recognized OEM’s, including Samsung
  • A sales pipeline that stands at $93,000,000 (not a typo) as of August 2020
  • Already generating revenues in 2020

And last but not least, a secret weapon in its Executive Chairman David Luxton, whose companies under his leadership have generated over $1,000,000,000 (Yes, BILLION).  

The soldier systems market is projected to hit $14.5 Billion by 2023 and, up until  now, small cap investors have never had a company to participate in this lucrative (and SUPER COOL) market.  

Now you do.  Meet KWESST Micro Systems.  Watch this first ever interview with David Luxton himself to learn about where KWESST is going.  

Watch this interview or listen by Podcast on AppleGoogleSpotify or your favourite podcaster.

Labrador Gold $LAB.ca Appoints Mr. Matthieu Lapointe Vice President Exploration $RIO.ca $WHM.ca $SIC.ca $NXS.ca $NVO.ca $CFE.ca

Posted by AGORACOM at 8:10 AM on Thursday, October 1st, 2020

TORONTO, Oct. 01, 2020 (GLOBE NEWSWIRE) — Labrador Gold Corp. (TSX.V:LAB | OTCQX:NKOSF | FNR: 2N6) (“LabGold” or the “Company”) is pleased to announce the appointment of Matthieu (Matt) Lapointe as VP Exploration effective immediately.

Mr. Lapointe, P.Geo. has over 15 years of greenfield and brownfield precious metal exploration throughout Canada and internationally. Most recently Mr. Lapointe was Chief Geologist for TMAC Resources where he developed exploration strategy and managed regional exploration of the 1,600 km2 Hope Bay Project in Nunavut including brownfield targeting at the active Doris gold mine and two advanced stage gold deposits.

“I am very pleased to welcome Matt to the LabGold technical team,” said Roger Moss, President and CEO of the Company. “He is a seasoned explorationist well versed in evaluating large land packages and advancing projects from grassroots to production stages. I expect him to have an immediate impact on our exploration program at Kingsway, especially as we gear up for our fall drilling campaign.”

Matt Lapointe commented, “I am pleased to join the LabGold team as the company begins the next phases of exploration. LabGold has assembled an impressive property portfolio and have been systematically exploring highly prospective areas. The progress and results to date are encouraging and I look forward to continue advancing these exciting projects.”

Roger Moss, PhD., P.Geo., is the qualified person responsible for all technical information in this release.

About Labrador Gold
Labrador Gold is a Canadian based mineral exploration company focused on the acquisition and exploration of prospective gold projects in Eastern Canada.

In early March 2020, Labrador Gold acquired the option to earn a 100% interest in the Kingsway project in the Gander area of Newfoundland. The property is along strike to the northeast of New Found Gold’s discovery of 92.86 g/t Au over 19.0 metres on their Queensway property. (Note that mineralization hosted on adjacent or nearby properties is not necessarily indicative of mineralization hosted on the Company’s property). In early July 2020, the Company signed an option agreement to acquire a third license to add to the property package which now covers approximately 77 km2. The three licenses comprising the Kingsway project cover approximately 16km of the Appleton fault zone which is associated with gold occurrences in the region, including the New Found Gold discovery. Historical work over the area covered by the Kingsway licenses shows evidence of gold in till, vegetation, soil, stream sediments, lake sediments and float. Infrastructure in the area is excellent located just 18km from the town of Gander with road access to the project, nearby electricity and abundant local water.

The Hopedale property covers much of the Hunt River and Florence Lake greenstone belts that stretch over 80 km. The belts are typical of greenstone belts around the world but have been underexplored by comparison. Initial work by Labrador Gold during 2017 show gold anomalies in soils and lake sediments over a 3 kilometre section of the northern portion of the Florence Lake greenstone belt in the vicinity of the known Thurber Dog gold showing where grab samples assayed up to 7.8g/t gold. In addition, anomalous gold in soil and lake sediment samples occur over approximately 40 kilometres along the southern section of the greenstone belt (see news release dated January 25th 2018 for more details). Labrador Gold now controls approximately 57km strike length of the Florence Lake Greenstone Belt.

The Ashuanipi gold project is located just 35 km from the historical iron ore mining community of Schefferville, which is linked by rail to the port of Sept Iles, Quebec in the south. The claim blocks cover large lake sediment gold anomalies that, with the exception of local prospecting, have not seen a systematic modern day exploration program. Results of the 2017 reconnaissance exploration program following up the lake sediment anomalies show gold anomalies in soils and lake sediments over a 15 kilometre long by 2 to 6 kilometre wide north-south trend and over a 14 kilometre long by 2 to 4 kilometre wide east-west trend. The anomalies appear to be broadly associated with magnetic highs and do not show any correlation with specific rock types on a regional scale (see news release dated January 18th 2018). This suggests a possible structural control on the localization of the gold anomalies. Historical work 30 km north on the Quebec side led to gold intersections of up to 2.23 grams per tonne (g/t) Au over 19.55 metres (not true width) (Source: IOS Services Geoscientifiques, 2012, Exploration and geological reconnaissance work in the Goodwood River Area, Sheffor Project, Summer Field Season 2011). Gold in both areas appears to be associated with similar rock types.

The Company has 93,294,175 common shares issued and outstanding and trades on the TSX Venture Exchange under the symbol LAB.

For more information please contact:             

Roger Moss, President and CEO      Tel: 416-704-8291

Or visit our website at: www.labradorgold.com

Twitter: @LabGoldCorp